Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Publication Year: 2024 Source: Gastroenterol Hepatol PMID: 38311005
No Abstract
Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease-EXVEDOCOL
Publication Year: 2024 Source: Gastroenterol Hepatol PMID: 38311006 DOI: 10.1016/j.gastrohep.2024.01.009
BACKGROUND: Real-world studies about the effectiveness and safety of vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD) in Latin America are scarce. Our study describes the effectiveness and safety of VDZ in Colombian patients with IBD. METHODS: EXVEDOCOL (EXperience of VEDOlizumab in COLombia) was a retrospective, multicenter, observational …
Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis
Publication Year: 2024 Source: Eur J Pharm Biopharm PMID: 38311187
No Abstract
[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]
Publication Year: 2024 Source: Rinsho Ketsueki PMID: 38311388
No Abstract
Letter to the Editor: Switching from vedolizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study
Publication Year: 2024 Source: Dig Liver Dis PMID: 38311530 DOI: 10.1016/j.dld.2024.01.187
No Abstract
[Association of ITGA4 and ICAM-1 gene polymorphisms with the risk and clinicopathological characteristics of Crohn's disease]
Publication Year: 2024 Source: Zhonghua Yi Xue Yi Chuan Xue Za Zhi PMID: 38311553
No Abstract
[Clinical features and genetic analysis of three patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome due to variants of FOXP3 gene]
Publication Year: 2024 Source: Zhonghua Yi Xue Yi Chuan Xue Za Zhi PMID: 38311556
No Abstract
Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing
Publication Year: 2024 Source: Intest Res PMID: 38311714
No Abstract
Enhancement of LC3-associated efferocytosis for the alleviation of intestinal inflammation
Publication Year: 2024 Source: Autophagy PMID: 38311819 DOI: 10.1080/15548627.2024.2311548
LC3-associated phagocytosis (LAP) is an instrumental machinery for the clearance of extracellular particles including apoptotic cells for the alleviation of inflammation. While pharmacological approaches to modulate LAP for inflammation regulation have been poorly explored, in our study we identified a novel compound, columbamine (COL), which can trigger LAP and enhance …
Mechanisms of Stem Cells and Their Secreted Exosomes in the Treatment of Autoimmune Diseases
Publication Year: 2024 Source: Curr Stem Cell Res Ther PMID: 38311916
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide